NCT02346058

Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins

Evaluate the Efficacy and Safety of Esarin Gel in the Treatment of Chronic Venous Insufficiency or Varicose Vein Combine With Superficial Vein Thrombophlebitis in Outpatient

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: Ten Sun Pharma Company Limited · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Evaluation efficacy and safety of Esarin Gel in subjects with chronic venous insufficiency or varicose veins combine superficial vein thrombophlebitis.

Detailed description

Open-label,non-controlled study design with three visits (pre-treatment/baseline, treatment day 14 and day 28). Administered Esarin Gel twice daily for 28 days in subjects with chronic venous insufficiency rated between CEAP 0 and 3 or varicose veins combine superficial vein thrombophlebitis, in comparison to the pre-treatment.

Conditions

• Chronic Venous Insufficiency
• Varicose Vein
• Superficial Vein Thrombophlebitis

Interventions

Type	Name	Description
DRUG	Esarin Gel

Timeline

• Start date: 2013-10-01
• Primary completion: 2014-06-01
• Completion: 2014-10-01
• First posted: 2015-01-26
• Last updated: 2015-01-26

Locations

1 site across 1 country: Taiwan